Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of LY2523355 in Participants With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents
- Status
- COMPLETED
- Phase
- N/A
Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Fresolimumab and Radiotherapy in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Imaging of Fulvestrant Effects on Availability of ER Binding Sites
- Status
- COMPLETED
- Phase
- PHASE2
Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers
- Status
- WITHDRAWN
- Phase
- NA
A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1
Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2